A gift of life: Ethical and practical problems with conditional and directed donation.
Volk M, Ubel PA. Transplantation. 85(11):1542-1544, 2008.

Liver transplantation for hepatocellular carcinoma: Who benefits and who is harmed?
Volk M, Marrero JA. Gastroenterology . 134:1612-1614, 2008.

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria.
Volk M, Vijan S, Marrero JA. American Journal of Transplantation. 8:839-846, 2008.

Early detection of liver cancer: Diagnosis and management.
Volk M, Marrero JA. Current Opinion in Gastroenterology. 10(1):60-66, 2008.

Modified Charlson comorbidity index for predicting survival after liver transplantation.
Volk M, Hernandez JC, Lok AS, Marrero JA. Liver Transplantation. 13:1515-1520, 2007.

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: A comparison of AFP, DCP, and AFP-L3.
Volk M, Hernandez JC, Su G, Lok AS, Marrero JA. Cancer Biomarkers. 3(2):79-87, 2007.

Who decides? Living donor liver transplantation for hepatocellular carcinoma.
Ubel PA, Volk M, Lok AS, Marrero JA. Transplantation. 82:1136-1139, 2006.

Advances in critical care hepatology.
Volk M, Marrero JA. Minerva Anestesiologica . 72(5):269-281, 2006.

Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine.
Burchett SA, Volk M, Bannon MJ, Granneman JG. Journal of Neurochemistry . 70:2216-2219, 1998.

Impact of MELD allocation policy on utilization of high risk organs for liver transplantation.
Volk M, Lok AS, Pelletier SJ, Ubel PA, Hayward RA. In Press.

Beyond utilitarianism: A method for examining competing ethical principles in a decision analysis of liver transplantation.
Volk M, Lok AS, Ubel PA, Vijan S. Medical Decision Making. In Press.